Dr.P.A. Jiwani Interventional Cardiologist in Hyderabad

Dr.P.A. Jiwani

Interventional Cardiologist, Hyderabad

MBBS, MD, D.Card, DNB (Card), MNAMS

  • 1 Hospital

Experience

Senior Consultant & Interventional Cardiologist, Krishna Institute of Medical Sciences & Superspeciality Hospital, Hyderabad

Specialities

  • Interventional Cardiology

Procedures

  • Coronary Angioplasty, Atherectomy and Stent

Expertise

Education

MBBS, 1977, Govt. Medical College, Nagpur

M.D (Medicine), 1981, Govt. Medical College, Nagpur

D.Card, 1989, University of London Royal Postgraduate Medical School Hamar Smith Hospital, London

DNB ( Cardiology), 1992, Nizam’s Institute of Medical Sciences, Hyderabad

Practice Information

KIMS Hospitals, Secunderabad

KIMS Hospitals, Secunderabad

1 - 8 - 31/1, Minister Road, Secunderabad, Hyderabad, Telangana - 500003

MON, TUE, WED, THU, FRI, SAT

10:00 AM - 04:00 PM

Achievements & Contributions

  • MICHELANGELO OASIS – 6 (STEMI) STUDY) – an international randomized study evaluating the efficacy and safety of Fondaparinux sodium vs. control therapy in broad range of patients with ST segment elevation Acute MI.
  • XIENCE V Registry –Xience Everolimus Eluting Coronary Stent System (EECSS) India Post Marketing Registry.
  • PLATO STUDY - A Randomized, Double blind, parallel group, phase 3, Efficacy and safety study of AZD6 140 Compared with Clopidogrel for prevention of vascular events in patients with Non –ST or ST elevation Acute Coronary Syndrome (ACS)
  • OASIS -7 (CURRENT) STUDY) – Randomized, Multinational, double blind study, comparing a high loading dose regimen of Clopidogrel versus standard dose in patient with Unstable Angina or myocardial infarction managed with an early invasive strategy – Oasis -7 Study.
  • LIFENOX STUDY – International multicenter, randomized, double blind study to compare the overall mortality in acutely ill medical patients treated with enoxaparin versus placebo in addition to Graduated Elastic Stockings. MICHELANGELO OASIS – 6 (STEMI) STUDY) – an international randomized study evaluating the efficacy and safety of Fondaparinux sodium vs. control therapy in broad range of patients with ST segment elevation Acute MI.
  • Life Member, Cardiology Society of India
  • Life Member, Academy of Medical Sciences, India
  • Life Member, Indian Medical Association
  • Member, Advisory Board, Krishna Institute of Medical Sciences, Secunderabad.
-->